Cardio Industry Puts Weight Behind UK Call For National CVD Strategy
Executive Summary
Better uptake of medtech in tackling cardiovascular disease can bring benefits across the entire pathway of care, say UK CVD companies, who are urging the government to improve levels of technology adoption.
You may also be interested in...
All Change For UK Health Care: Global Medtech Keeps A Close Watch
Shaped by Brexit, driven by COVID, squeezed by budgets and being engineered for the future, it seems that almost every element within UK health delivery and market access is undergoing change. How should the medtech industry prepare, and will there be implications beyond the UK?
UK Medtechs Say Conditional Reimbursement Will Open Doors To Innovation Adoption
As the UK NHS Medtech Funding Mandate finally becomes live, the medtech industry is pressing the case for another mechanism that will allow more innovation onto the UK market.
Further Transition Period Mooted As Eurasian Device System Comes Into Force To Little Fanfare
After a five-year regulatory transition, access to the Eurasian Economic Union market for new medtech products must now take place via the EAEU system only. But having got off to a slow start, further system transitional measures are now under discussion.